\BOOKMARK [1][-]{section.1}{Abstract}{}% 1
\BOOKMARK [1][-]{section.2}{Introduction}{}% 2
\BOOKMARK [1][-]{section.3}{Methods}{}% 3
\BOOKMARK [2][-]{subsection.3.1}{Study population}{section.3}% 4
\BOOKMARK [2][-]{subsection.3.2}{Biweekly surveillance of RSV infection}{section.3}% 5
\BOOKMARK [2][-]{subsection.3.3}{Descriptive analyses}{section.3}% 6
\BOOKMARK [2][-]{subsection.3.4}{RSV whole-genome sequencing}{section.3}% 7
\BOOKMARK [2][-]{subsection.3.5}{Viral Sequence alignment}{section.3}% 8
\BOOKMARK [2][-]{subsection.3.6}{Population structure}{section.3}% 9
\BOOKMARK [2][-]{subsection.3.7}{Association testing}{section.3}% 10
\BOOKMARK [2][-]{subsection.3.8}{Biological interpretation}{section.3}% 11
\BOOKMARK [1][-]{section.4}{Results}{}% 12
\BOOKMARK [2][-]{subsection.4.1}{Cohort characteristics}{section.4}% 13
\BOOKMARK [2][-]{subsection.4.2}{Population structure}{section.4}% 14
\BOOKMARK [2][-]{subsection.4.3}{Genetic invariance of persistent infection}{section.4}% 15
\BOOKMARK [2][-]{subsection.4.4}{Variants in G glycoprotein significantly associated with persistent infection}{section.4}% 16
\BOOKMARK [2][-]{subsection.4.5}{Functional interpretation}{section.4}% 17
\BOOKMARK [2][-]{subsection.4.6}{Other notes}{section.4}% 18
\BOOKMARK [1][-]{section.5}{Discussion}{}% 19
\BOOKMARK [1][-]{section.6}{Links}{}% 20
\BOOKMARK [2][-]{subsection.6.1}{Software}{section.6}% 21
\BOOKMARK [2][-]{subsection.6.2}{Additional Data sources}{section.6}% 22
\BOOKMARK [1][-]{section.7}{Code availability}{}% 23
\BOOKMARK [1][-]{section.8}{On-line supplement Methods:}{}% 24
\BOOKMARK [2][-]{subsection.8.1}{Host GWAS for genetic susceptibility to infection}{section.8}% 25
\BOOKMARK [1][-]{section.9}{Tables and Figures}{}% 26
